Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H14O6S2.2C6H5Hg |
| Molecular Weight | 981.85 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Hg+]C1=CC=CC=C1.[Hg+]C2=CC=CC=C2.[O-]S(=O)(=O)C3=CC4=C(C=CC=C4)C=C3CC5=C(C=C6C=CC=CC6=C5)S([O-])(=O)=O
InChI
InChIKey=KDNVJBRRDKAHDA-UHFFFAOYSA-L
InChI=1S/C21H16O6S2.2C6H5.2Hg/c22-28(23,24)20-12-16-7-3-1-5-14(16)9-18(20)11-19-10-15-6-2-4-8-17(15)13-21(19)29(25,26)27;2*1-2-4-6-5-3-1;;/h1-10,12-13H,11H2,(H,22,23,24)(H,25,26,27);2*1-5H;;/q;;;2*+1/p-2
| Molecular Formula | C6H5Hg |
| Molecular Weight | 277.69 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C21H14O6S2 |
| Molecular Weight | 426.462 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Hydrargaphen (also known as penotrane) was studied in trials for patients with herpes genitalia. In the treatment of Trichomonas vaginalis infections, penotrane was the suitable treatment for those patients who have not responded to other treatments. Information about the current use of this drug is not available.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparison of nystatin ('Nystan') and hydrargaphen ('Penotrane') in the treatment of vaginal candidosis in pregnancy. | 1973 |
|
| HERPES GENITALIS. SURVEY OF THIRTY CASES AND EFFECT OF TREATMENT WITH "PENOTRANE" JELLY. | 1963-09 |
|
| The effect of penotrane on the growth in vitro of Candida albicans and Aspergillus fumigatus. | 1952-10 |
|
| Trichomonas vaginalis infections treated with "penotrane". | 1951-08-25 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14066172
The patient was instructed to apply the jelly liberally twice a day to the lesions and to return after 3 days and after 7 days of treatment.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:47:31 GMT 2025
by
admin
on
Mon Mar 31 18:47:31 GMT 2025
|
| Record UNII |
DL2D409P9O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID901016603
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
238-107-1
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
DL2D409P9O
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
10350985
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
C005041
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
m239
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
14235-86-0
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
100000084213
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
hydrargaphen
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
945
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
C170045
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY | |||
|
SUB08060MIG
Created by
admin on Mon Mar 31 18:47:31 GMT 2025 , Edited by admin on Mon Mar 31 18:47:31 GMT 2025
|
PRIMARY |